Zymeworks enters into ATM equity offering agreement with Cantor Fitzgerald

Zymeworks Inc.

Sales Agreement allows at-the-market sales of common stock through Cantor as agent.
Commission of up to 3.0% of gross proceeds; company not obligated to sell shares.
Offering under existing S-3ASR; prospectus supplement filed November 9, 2022.
Provides flexible capital raising subject to market conditions and company instructions.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Zymeworks Inc. entered into Sales Agreement with Cantor Fitzgerald & Co. (effective 2022-11-09).

Action: entry
Agreement: atm program
Counterparty: Cantor Fitzgerald & Co.
Effective: 2022-11-09

Exact text from the filing

On November 9, 2022, Zymeworks Inc. (the “Company”) entered into a Sales Agreement, dated as of November 9, 2022, (the “Sales Agreement”) with Cantor Fitzgerald & Co. (“Cantor”).

View on SEC.gov

24 material agreements filed in the last 30 days. Browse all material agreements →

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-281294

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.